Pharnext – This biopharmaceutical company has an interesting approach to find a cure for rare conditions that do not currently have a cure or treatment.

Pharnext is an advanced clinical-stage biopharmaceutical company founded in April 2007 by renowned scientists and entrepreneurs including Professor Daniel Cohen and collaborators, pioneers in modern genomics. The company develops new therapeutics for neurodegenerative diseases – orphan and common – where there are currently no cures and existing therapies available. 

For more info click here